Identification of Prognostic Long Non-Coding RNAs and Molecular Subtypes Related to the Hippo-Yes-Associated Protein Signalling in Osteosarcoma

被引:0
|
作者
Zheng, Chunlei [1 ]
Xu, Bing [2 ]
机构
[1] Tongxiang First Peoples Hosp, Dept Orthoped, Tongxiang 314500, Zhejiang, Peoples R China
[2] Tongxiang First Peoples Hosp, Dept Pediat, Tongxiang 314500, Zhejiang, Peoples R China
关键词
osteosarcoma; lncRNA; Hippo signalling pathway; molecular subtype; CANCER CELL-PROLIFERATION; LNCRNA SNHG5; IMMUNE CELLS; MODELS; GENE;
D O I
10.23812/j.biol.regul.homeost.agents.20233704.195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The Hippo signalling pathway is involved in cell proliferation, apoptosis, invasion and metastasis of osteosarcoma (OS). The purpose of the study is to explore the prognostic role of long non-coding RNAs (lncRNAs) related to Hippo signalling pathway and identify the molecular subtypes of OS. Methods: Gene expression data of OS were obtained from the TCGA (The Cancer Genome Atlas) and GEO databases. The cor-relation between lncRNAs and Hippo signalling pathway-related genes was investigated. Next, prognostic lncRNAs were selected through univariate Cox regression analysis, followed by disease subtype analysis and prognostic model construction.Results: A total of 57 lncRNAs significantly correlated with Hippo signalling pathway-related genes and prognosis were then screened. A total of 16 independent prognostic lncRNAs were obtained, including eight lncRNAs with optimised lncRNAs com-bination. A prognostic score (PS) model was then constructed. Finally, a nomogram survival model for independent survival prognostic factors was constructed. Patient's age, tumour metastasis and PS status were identified as the three factors with sig-nificant independent prognostic correlation.Conclusions: Eight Hippo signalling pathway-related lncRNAs, such as ABHD11-AS1, SPACA6P-AS and SNHG5, may serve as novel prognostic factors for OS.
引用
收藏
页码:1969 / 1978
页数:10
相关论文
共 50 条
  • [11] Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma
    Ferretti, Valeria A.
    Leon, Ignacio E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (05)
  • [12] Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma
    Valeria A. Ferretti
    Ignacio E. León
    Current Treatment Options in Oncology, 2021, 22
  • [13] Identification and function of long non-coding RNAs
    Young, Robert S.
    Ponting, Chris P.
    ROLE OF NON-CODING RNAS IN BIOLOGY, 2013, 54 : 113 - 126
  • [14] Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers
    Klinge, Carolyn M.
    ENDOCRINE-RELATED CANCER, 2018, 25 (04) : R259 - R282
  • [15] Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma
    Rothzerg, Emel
    Ho, Xuan Dung
    Xu, Jiake
    Wood, David
    Maertson, Aare
    Koks, Sulev
    GENES, 2021, 12 (08)
  • [16] Identification of BRAF inhibitor resistance associated long non-coding RNAs
    Toshima, Rika
    Wen, Xuan
    Han, Min
    Hosoya, Msaski
    Onishi, Mai
    Yamaguchi, Shigeo
    Fujii, Tomoaki
    Kato, Shunsuke
    CANCER SCIENCE, 2024, 115 : 681 - 681
  • [17] Long Non-Coding RNAs and Related Molecular Pathways in the Pathogenesis of Epilepsy
    Villa, Chiara
    Lavitrano, Marialuisa
    Combi, Romina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [18] Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes
    Claudia Cava
    Alexandros Armaos
    Benjamin Lang
    Gian G. Tartaglia
    Isabella Castiglioni
    Scientific Reports, 12
  • [19] Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes
    Cava, Claudia
    Armaos, Alexandros
    Lang, Benjamin
    Tartaglia, Gian G.
    Castiglioni, Isabella
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [20] Identification of Two Subtypes and Prognostic Characteristics of Lung Adenocarcinoma Based on Pentose Phosphate Metabolic Pathway-Related Long Non-coding RNAs
    Liu, Chuan
    Wang, Yongjie
    FRONTIERS IN PUBLIC HEALTH, 2022, 10